Graf Akcie USNA (Usana Health Sciences Inc). Diskuze k akciím USNA. Aktuální informace USNA.

Základní informace o společnosti Usana Health Sciences Inc (Akcie USNA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1.94B
Hodnota podniku (EV) 1.48B
Tržby 1.254B
EBITDA 222.323M
Zisk 138.99M
Růst v tržbách Q/Q 30.06 %
Růst v tržbách Y/Y 18.57 %
P/E (Cena vůči ziskům) 14.67
Forward P/E N/A
EV/Sales 1.18
EV/EBITDA 6.67
EV/EBIT 7.50
PEG 1.02
Price/Sales 1.55
P/FCF 13.10
Price/Book 4.40
Účetní hodnota na akcii 22.30
Hotovost na akcii 15.75
FCF vůči ceně 7.63 %
Počet zaměstnanců 1,943
Tržba na zaměstnance 645.315k
Profit margin 10.99 %
Operating margin 15.62 %
Gross margin 81.57 %
EBIT margin 15.77 %
EBITDA margin 17.73 %
EPS - Zisk na akcii 6.69
EPS - Kvartální růst 41.67 %
EPS - Očekávaný růst příští rok 0.00 %
Return on assets 23.22 %
Return on equity 33.65 %
ROIC 30.83 %
ROCE 45.10 %
Dluhy/Equity 0.45
Čistý dluh/EBITDA -5.00
Current ratio 2.49
Quick Ratio 1.91
Volatilita 1.88
Beta 0.59
RSI 65.67
Cílová cena analytiků 100
Známka akcie (dle analytiků) 2.00
Insider ownership 39.58 %
Institutional ownership 58.51 %
Počet akcií 20.012M
Procento shortovaných akcií 5.38 %
Short ratio 9.38 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2011
Země United States

Finanční výsledky akcie USNA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1,134.644$1,060.902$1,189.248$1,047.265$1,006.083$918.499
Cost Of Goods Sold$209.111$187.503$200.71$179.404$180.19$159.682
Gross Profit$925.533$873.399$988.538$867.861$825.893$758.817
Research And Development Expenses------
SG&A Expenses$749.042$727.209$800.185$735.357$687.271$617.155
Other Operating Income Or Expenses------
Operating Expenses$958.153$914.712$1,000.895$914.761$867.461$776.837
Operating Income$176.491$146.19$188.353$132.504$138.622$141.662
Total Non-Operating Income/Expense$1.457$4.306$3.157$2.136$-0.07$0.927
Pre-Tax Income$177.948$150.496$191.51$134.64$138.552$142.589
Income Taxes$53.284$49.97$65.286$72.105$38.511$47.917
Income After Taxes$124.664$100.526$126.224$62.535$100.041$94.672
Other Income------
Income From Continuous Operations$124.664$100.526$126.224$62.535$100.041$94.672
Income From Discontinued Operations------
Net Income$124.664$100.526$126.224$62.535$100.041$94.672
EBITDA$176.491$169.197$205.196$148.614$152.104$151.64
EBIT$176.491$146.19$188.353$132.504$138.622$141.662
Basic Shares Outstanding-2324242425
Shares Outstanding212325252526
Basic EPS-$4.44$5.24$2.57$4.14$3.72
EPS - Earnings Per Share$5.86$4.41$5.12$2.53$3.99$3.59
# 2020 2019 2018 2017 2016 2015
Current Ratio2.41942.63872.40932.00631.85881.7564
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin82.326183.12382.869382.0982.614982.1886
Operating Margin13.779815.83812.652413.778415.423214.6877
EBIT Margin13.779815.83812.652413.778415.423214.6877
EBITDA Margin15.948417.254314.190715.118416.509615.8022
Pre-Tax Profit Margin14.185716.103512.856413.771415.524114.6309
Net Profit Margin9.475510.61385.97139.943610.30739.695
Asset Turnover2.05232.14492.01682.13772.17022.2547
Inventory Turnover Ratio2.72122.44922.85142.78032.41513.1116
Receiveable Turnover------
Days Sales In Receivables------
ROE - Return On Equity28.581932.270317.217330.754733.708933.2963
Return On Tangible Equity32.933936.851620.131136.481642.048244.7455
ROA - Return On Assets19.446622.765112.042921.256322.368621.8595
ROI - Return On Investment28.581932.270317.217330.754733.708933.2963
Book Value Per Share16.241616.597215.118613.285211.24499.1096
Operating Cash Flow Per Share-0.61911.1637-0.45591.2360.38730.3609
Free Cash Flow Per Share-0.8961.24940.3150.82420.2396-0.1029